Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

572 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.
Rahbari NN, Biondo S, Frago R, Feißt M, Kreisler E, Rossion I, Serrano M, Jäger D, Lehmann M, Sommer F, Dignass A, Bolling C, Vogel I, Bork U, Büchler MW, Folprecht G, Kieser M, Lordick F, Weitz J; SYNCHRONOUS and CCRe-IV Trial Groups. Rahbari NN, et al. Among authors: jager d. J Clin Oncol. 2024 May 1;42(13):1531-1541. doi: 10.1200/JCO.23.01540. Epub 2024 Feb 27. J Clin Oncol. 2024. PMID: 38412408 Clinical Trial.
Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up.
Stelmach R, Apostolidis L, Kahle S, Sisic L, Nienhüser H, Weber TF, Jäger D, Haag GM. Stelmach R, et al. Among authors: jager d. J Cancer Res Clin Oncol. 2023 Nov;149(16):14785-14796. doi: 10.1007/s00432-023-05254-4. Epub 2023 Aug 17. J Cancer Res Clin Oncol. 2023. PMID: 37589924 Free PMC article.
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors.
Helisch A, Kratochwil C, Kleist C, Krämer S, Rosales Castillo JJ, Dendl K, Rathke H, von Goetze I, Schreckenberger M, Jäger D, Lindner T, Mier W, Giesel F, Haberkorn U, Röhrich M. Helisch A, et al. Among authors: jager d. J Nucl Med. 2024 Dec 3;65(12):1917-1922. doi: 10.2967/jnumed.124.268386. J Nucl Med. 2024. PMID: 39477492
Effects of parenteral nutrition + best supportive nutritional care vs. best supportive nutritional care alone on quality of life in patients with pancreatic cancer-a secondary analysis of PANUSCO.
Emanuel A, Rosenberger F, Krampitz J, Decker-Baumann C, Märten A, Jäger D, Rötzer I. Emanuel A, et al. Among authors: jager d. Support Care Cancer. 2024 Jun 27;32(7):466. doi: 10.1007/s00520-024-08666-1. Support Care Cancer. 2024. PMID: 38935156 Free PMC article.
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.
Le DT, Diaz LA Jr, Kim TW, Van Cutsem E, Geva R, Jäger D, Hara H, Burge M, O'Neil BH, Kavan P, Yoshino T, Guimbaud R, Taniguchi H, Élez E, Al-Batran SE, Boland PM, Cui Y, Leconte P, Marinello P, André T. Le DT, et al. Among authors: jager d. Eur J Cancer. 2023 Jun;186:185-195. doi: 10.1016/j.ejca.2023.02.016. Epub 2023 Feb 24. Eur J Cancer. 2023. PMID: 37141828
A precision-based exercise program for patients with multiple myeloma.
Dapunt U, Ehret P, Paratte JL, Kuehl RM, Wiskemann J, Jäger D, Müller-Tidow C, Raab MS, Goldschmidt H. Dapunt U, et al. Among authors: jager d. Eur J Haematol. 2023 Dec;111(6):930-937. doi: 10.1111/ejh.14106. Epub 2023 Sep 20. Eur J Haematol. 2023. PMID: 37727991
Graph machine learning for integrated multi-omics analysis.
Valous NA, Popp F, Zörnig I, Jäger D, Charoentong P. Valous NA, et al. Among authors: jager d. Br J Cancer. 2024 Jul;131(2):205-211. doi: 10.1038/s41416-024-02706-7. Epub 2024 May 10. Br J Cancer. 2024. PMID: 38729996 Free PMC article. Review.
572 results